Related references
Note: Only part of the references are listed.Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation
Yacine Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Rapid Selection of Oseltamivir- and Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2010)
A Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 Influenza
Le Quynh Mai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rare Influenza A (H3N2) Variants with Reduced Sensitivity to Antiviral Drugs
Clyde Dapat et al.
EMERGING INFECTIOUS DISEASES (2010)
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Aeron C. Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
Scott A. Harper et al.
CLINICAL INFECTIOUS DISEASES (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
Global Transmission of Oseltamivir-Resistant Influenza
Anne Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Mariana Baz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
Honglin Chen et al.
EMERGING INFECTIOUS DISEASES (2009)
Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes
Yacine Abed et al.
ANTIVIRAL RESEARCH (2008)
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants
Patrick J. Collins et al.
NATURE (2008)
Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo
Hui-Ling Yen et al.
JOURNAL OF VIROLOGY (2007)
Possible avian influenza (H5N1) from migratory bird, Egypt
Magdi D. Saad et al.
EMERGING INFECTIOUS DISEASES (2007)
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir
Mariana Baz et al.
ANTIVIRAL RESEARCH (2007)
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an Immunocompromised child
Mariana Baz et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro
Thomas Zurcher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
Arnold S. Monto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Recovery of drug-resistant influenza virus from immunocompromised patients: A case series
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Treatment of respiratory virus infections
Yacine Abed et al.
ANTIVIRAL RESEARCH (2006)
Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
MD de Jong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors
VP Mishin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Enhanced expression of an α2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor
S Hatakeyama et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
LV Gubareva
VIRUS RESEARCH (2004)
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient
DM Weinstock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir
MZ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Oral oseltamivir treatment of influenza in children
RJ Whitley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2001)
Share Paper
